Skip to main content

Table 1 Comparison between groups of general data and intraoperative conditions

From: Effectiveness of perioperative low-dose esketamine infusion for postoperative pain management in pediatric urological surgery: a prospective clinical trial

Group

ES1 group(n = 20)

ES2 group(n = 18)

H1 group(n = 19)

H2 group(n = 19)

P value

Age (yr)

6.5[3.0-8.8]

3.0[2.0–6.0]

3.0[2.0–6.0]

4.0[3.0–8.0]

0.274

Height (cm)

124.0[97.0-139.8]

100.0[91.5-117.5]

102.0[96.0-120.0]

108.0[95.0-135.0]

0.297

Weight (kg)

24.5[15.0-39.8]

19.0[14.3–25.3]

17.0[15.0–25.0]

18.0[16.0–35.0]

0.404

ASA status ( I/II), N

17/3

15/3

15/4

15/4

0.957

Remifentanil consumption (ug)

358.0[191.0-536.8]

346.5[245.8-488.8]

394.0[228.0-500.0]

300.0[234.0-550.0]

0.965

Blood loss (ml)

5.0[4.0–6.0]

5.0[3.8–8.3]

5.0[3.0–6.0]

3.0[3.0–5.0]

0.073

Infusion volume (ml/h)

135.7[99.2-203.4]

107.5[89.9-131.5]

104.3[83.9-134.3]

121.6[68.2-160.7]

0.251

Type of surgery

 

0.548

Penile or urethroplasty (I/II), N

7/1

6/0

4/1

5/1

 

Penile correction (I/II), N

5/0

1/0

4/0

4/0

 

Penile or urethroplasty combined with penile straightening (I/II), N

5/2

7/1

6/0

6/1

 

Laparoscopic pyeloplasty

(I/II), N

0/0

1/2

1/3

0/2

 
  1. Data are presented as median (25th-75th percentile) or numbers(n/n). ASA: American society of anesthesiologists.